PhRMA Foundation - Advisory Committees
 
Advisory Committees
Scientific Advisory Committee

William R. Darrow, M.D., Ph.D.

Chief Science Advisor
William R. Darrow, M.D., Ph.D.
(Committee Chairman)
Senior Medical Advisor
Schering-Plough Research Institute
Kenilworth, New Jersey
 Darrell R. Abernethy, M.D., Ph.D.

Clinical Pharmacology Advisory Committee
Darrell R. Abernethy, M.D., Ph.D.
Chief Science Officer
United States Pharmacopeia
Rockville, Maryland
William J. Curatolo, Ph.D.

Pharmaceutics Advisory Committee
William J. Curatolo, Ph.D.
Senior Research Fellow
Pfizer Global Research & Development
Pfizer Inc.
Groton, Connecticut
 Joseph M. Davie, M.D., Ph.D

Informatics Advisory Committee
Joseph M. Davie, M.D., Ph.D.
Former Sr. Vice President of Research
Biogen
Cambridge, Massachusetts
George C. Fuller, Ph.D.

Basic Pharmacology Advisory Committee
George C. Fuller, Ph.D.
Professor Emeritus and Former Dean
Pharmaceutical Sciences
Wayne State University
Detroit, MI
 Jean Paul Gagnon, Ph.D.

Health Outcomes Advisory Committee
Jean Paul Gagnon, Ph.D.
Director, Public Policy
Sanofi-Aventis
Bridgewater, NJ
Informatics Advisory Committee

Joseph M. Davie, M.D., Ph.D.
(Chairman)
Former Sr. Vice President of Research
Biogen
Cambridge, Massachusetts/div>
George R. Lenz, Ph.D. MBA
GRLEN R&D Associates
Andover, Massachusetts
Michael N. Liebman, Ph.D.
Executive Director
Windber Research Institute
Windber, Pennsylvania
Peter A. Schad, Ph.D.
Health Informatics Coordinator
National Cancer Institute
Division of Cancer Control and Population Sciences
Rockville, Maryland
David B. Searls, Ph.D.
Senior Vice President
Worldwide Bioinformatics
GlaxoSmithKline
King of Prussia, Pennsylvania
Basic Pharmacology Advisory Committee

George C. Fuller, Ph.D.
(Chairman)
Professor Emeritus and Former Dean
Pharmaceutical Sciences
Wayne State University
Detroit, MI
Daniel Acosta, Jr., Ph.D.
Dean
College of Pharmacy
University of Cincinnati - Medical Ctr.
Cincinnati, Ohio
James W. Aiken, Ph.D.
President and CEO
Keystone Symposia on Molecular & Cellular Biology
Silverthorne, Colorado
Terry L. Bowlin, Ph.D.
Chief Scientific Officer
Microbiotix, Inc.
Worcester, MA 01605
Sue Piper Duckles, Ph.D.
Professor and Associate Dean
Department of Pharmacology
College of Medicine
University of California
Irvine, California
Salvatore J. Enna, Ph.D.
Professor
Department of Pharmacology
University of Kansas Medical Center
Kansas City, Kansas
Paul S. Guth, Ph.D.
Professor of Pharmacology
School of Medicine
Tulane University
New Orleans, Louisiana
Robert A. Kramer, Ph.D.
Vice President, Oncology and Immunology Drug Discovery
Bristol-Myers Squibb Company
Princeton, New Jersey
George R. Lenz, Ph.D. MBA
GRLEN R&D Associates
Andover, Massachusetts
Harry LeVine, III, Ph.D.
Center on Aging, Dept. of Molecular & Cellular Biochemistry
University of Kentucky
Lexington, Kentucky
Sidney Pestka, M.D.
Chairman and Professor
Department of Molecular Genetics and Microbiology and Immunology
University of Medicine & Dentistry of New Jersey
Robert Wood Johnson Medical School
Piscataway, New Jersey
Darryle D. Schoepp, Ph.D.
Senior Vice President & Franchise Head, Neuroscience
Merck Research Laboratories
North Wales, Pennsylvania
Patricia Seymour, M.D.
Associate Research Fellow
Pfizer Inc
Groton, Connecticut

Clinical Pharmacology Advisory Committee

Darrell R. Abernethy, M.D., Ph.D.
(Chairman)
Chief Science Officer
United States Pharmacopeia
Rockville, Maryland
Arthur J. Atkinson, Jr., M.D.
Adjunct Professor
Department of Molecular Pharmacology and Biochemistry
Feinberg School of Medicine
Northwestern University
Richland, Michigan
Thorir D. Bjornsson, M.D., Ph.D.
Vice President, Early Development and Clinical Pharmacology
Wyeth Pharmaceuticals
Collegeville, Pennsylvania
Terrence F. Blaschke, M.D.
Professor of Medicine and Molecular Pharmacology
Division of Clinical Pharmacology
Stanford University, School of Medicine
Stanford, California
Glenn Gormley, M.D., Ph.D.
Senior Vice President and Global Head
Clinical Development and Medical Affairs
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey
Perry V. Halushka, M.D., Ph.D
Professor of Pharmacology and Medicine
Dean, College of Graduate Studies
Medical University of South Carolina
Charleston, South Carolina

Pharmaceutics Advisory Committee

William J. Curatolo, Ph.D.
(Chairman)
Senior Research Fellow
Pfizer Global Research & Development
Pfizer Inc
Groton, Connecticut
Bradley D. Anderson, Ph.D.
H.B. Kostenbauder Professor
University of Kentucky
Lexington, Kentucky
Michael J. Hageman, Ph.D.
Group Director
Bristol-Myers Squibb Company
Princeton, New Jersey
Charles Russel Middaugh, Ph.D.
Distinguished Professor of Pharmaceutical Chemistry
University of Kansas
Lawrence, Kansas
Patrick J. Sinko, Ph.D.
Associate Vice President for Research
Rutgers, The State University of New Jersey
Parke-Davis Professor of Pharmaceutics & Drug Delivery
Piscataway, New Jersey

Health Outcomes Advisory Committee

Jean Paul Gagnon, Ph.D.
(Chairman)
Director, Public Policy
Sanofi-Aventis
Bridgewater, New Jersey
Lyle Bootman, Ph.D.
Dean
College of Pharmacy
University of Arizona
Tucson, Arizona
Robin P. Hertz, PhD
Senior Director
Population Studies
US Outcomes Research
Pfizer Global Pharmaceuticals
New York, New York
C. Daniel Mullins, Ph.D.
Professor and Chair
Pharmaceutical Health Services
Research Department
University of Maryland School of Pharmacy
Baltimiore, Maryland
Nancy C. Santanello, MD, MS
Vice President, Epidemiology
Merck Research Laboratories
North Wales, Pennsylvania
Sean D. Sullivan, Ph.D.
Professor and Director
Pharmaceutical Outcomes Research & Policy Program
Department of Pharmacy
University of Washington
Seattle, Washington